Back to Trials
NCT05391828NARecruiting

Persona MC vs PS RCT With ROSA

NYU Langone Health

Start Date

9/27/2023

Completion Date

12/1/2028

Summary

A randomized, controlled study comparing two total knee implant devices, Persona medial congruent (MC) vs posterior stabilized (PS). These surgeries will be performed using the ROSA robotic system. Patients will be followed up to 5 years.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: 1. Patients ≥18 years of age 2. Patients scheduled an elective primary TKA for a diagnosis of osteoarthritis or inflammatory arthritis using the ROSA Knee System. 3. Patient is willing to cooperate and follow study protocol and visit schedule 4. Subject has access to a device is capable of pairing to the Apple Watch, supporting application updates and is compatible with the mymobility App. Exclusion Criteria: 1. Patient is pregnant 2. Patient is unable to provide written consent 3. Revision TKA 4. History of prior infection in the affected knee 5. History of prior open surgery with significant hardware in place on the affected knee (i.e. prior distal femur or proximal tibia fracture or osteotomy) 6. Preoperative diagnosis of post-traumatic arthritis, avascular necrosis, or fracture

Interventions

DEVICE

Zimmer-Biomet Persona Medial Congruent (MC) Bearing Design

DEVICE

Zimmer-Biomet Persona Posterior-Stabilized (PS) Bearing Design

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Total Knee Arthroplasty

Locations

NYU Langone Health

New York, New York 10016

United States